Cristóbal, I.; Torrejón, B.; Rubio, J.; Santos, A.; Pedregal, M.; Caramés, C.; Zazo, S.; Luque, M.; Sanz-Alvarez, M.; Madoz-Gúrpide, J.;
et al. Deregulation of SET is Associated with Tumor Progression and Predicts Adverse Outcome in Patients with Early-Stage Colorectal Cancer. J. Clin. Med. 2019, 8, 346.
https://doi.org/10.3390/jcm8030346
AMA Style
Cristóbal I, Torrejón B, Rubio J, Santos A, Pedregal M, Caramés C, Zazo S, Luque M, Sanz-Alvarez M, Madoz-Gúrpide J,
et al. Deregulation of SET is Associated with Tumor Progression and Predicts Adverse Outcome in Patients with Early-Stage Colorectal Cancer. Journal of Clinical Medicine. 2019; 8(3):346.
https://doi.org/10.3390/jcm8030346
Chicago/Turabian Style
Cristóbal, Ion, Blanca Torrejón, Jaime Rubio, Andrea Santos, Manuel Pedregal, Cristina Caramés, Sandra Zazo, Melani Luque, Marta Sanz-Alvarez, Juan Madoz-Gúrpide,
and et al. 2019. "Deregulation of SET is Associated with Tumor Progression and Predicts Adverse Outcome in Patients with Early-Stage Colorectal Cancer" Journal of Clinical Medicine 8, no. 3: 346.
https://doi.org/10.3390/jcm8030346
APA Style
Cristóbal, I., Torrejón, B., Rubio, J., Santos, A., Pedregal, M., Caramés, C., Zazo, S., Luque, M., Sanz-Alvarez, M., Madoz-Gúrpide, J., Rojo, F., & GarcÃa-Foncillas, J.
(2019). Deregulation of SET is Associated with Tumor Progression and Predicts Adverse Outcome in Patients with Early-Stage Colorectal Cancer. Journal of Clinical Medicine, 8(3), 346.
https://doi.org/10.3390/jcm8030346